Table: begin end state 1 29 cytoplasmic 30 52 transmembrane 53 63 non-cytoplasmic 64 87 transmembrane 88 93 cytoplasmic 94 116 transmembrane 117 127 non-cytoplasmic 128 152 transmembrane 153 154 cytoplasmic 155 176 transmembrane 177 188 non-cytoplasmic 189 217 transmembrane 218 244 cytoplasmic 245 267 transmembrane 268 277 non-cytoplasmic 278 297 transmembrane 298 303 cytoplasmic 304 324 transmembrane 325 330 non-cytoplasmic 331 350 transmembrane 351 359 cytoplasmic
Input: >HSERO_RS05180 MSASMDSKLIPDTAASAGSPMLAGLLRHPLVRPLGALAVLLLIDFLLVPGFFKLEIKDGH LYGALIDIINRAAPLMLAALGMTLVIATRGVDISVGAVVAISGAVAAILIGGKMVVVDGV SQYVSNVPMVWALCAAMGAALLCGAWNGLLVAGLGLQPIIATLILMVAGRGLAQLLTDGQ IVTVYYKPFFFLGGGYLFGLPFSLYIAAAMFVLLALLMKKTALGLFIESVGINPVASRLA GIRTAALIFFVYMFCSACAGLAGLMIASNIKSADANNAGLLLELDAILAVTLGGTSLAGG KFSLVGSVIGALIIQTLTYTIYSLGVPPEVNMVVKSIVVFLVCLSQSPQFRRMLRMSKS
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server